Limits...
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey.

Gallo M, Mannucci E, De Cosmo S, Gentile S, Candido R, De Micheli A, Di Benedetto A, Esposito K, Genovese S, Medea G, Ceriello A - BMJ Open Diabetes Res Care (2015)

Bottom Line: The results of the survey show wide agreement (>90%) by participants on the utility of the algorithms proposed, even if they do not cover all possible needs of patients with T2DM for a personalized therapeutic approach.In the online survey period and in the months after its conclusion, a relevant and durable increase in the number of unique users who visited the websites was registered, compared to the period preceding the survey.Patients with T2DM are heterogeneous, and there is interest toward accessible and easy to use personalized therapeutic algorithms.

View Article: PubMed Central - PubMed

Affiliation: Department of Oncological Endocrinology , AOU Città della Salute e della Scienza-Molinette , Turin , Italy.

ABSTRACT

Objective: In recent years increasing interest in the issue of treatment personalization for type 2 diabetes (T2DM) has emerged. This international web-based survey aimed to evaluate opinions of physicians about tailored therapeutic algorithms developed by the Italian Association of Diabetologists (AMD) and available online, and to get suggestions for future developments. Another aim of this initiative was to assess whether the online advertising and the survey would have increased the global visibility of the AMD algorithms.

Research design and methods: The web-based survey, which comprised five questions, has been available from the homepage of the web-version of the journal Diabetes Care throughout the month of December 2013, and on the AMD website between December 2013 and September 2014. Participation was totally free and responders were anonymous.

Results: Overall, 452 physicians (M=58.4%) participated in the survey. Diabetologists accounted for 76.8% of responders. The results of the survey show wide agreement (>90%) by participants on the utility of the algorithms proposed, even if they do not cover all possible needs of patients with T2DM for a personalized therapeutic approach. In the online survey period and in the months after its conclusion, a relevant and durable increase in the number of unique users who visited the websites was registered, compared to the period preceding the survey.

Conclusions: Patients with T2DM are heterogeneous, and there is interest toward accessible and easy to use personalized therapeutic algorithms. Responders opinions probably reflect the peculiar organization of diabetes care in each country.

No MeSH data available.


Related in: MedlinePlus

Total respondents (N=452) divided according to specialty practice, that is, diabetologists/endocrinologists (N=347), other specialties (n=67) or general practitioner (n=38).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4537916&req=5

BMJDRC2015000109F1: Total respondents (N=452) divided according to specialty practice, that is, diabetologists/endocrinologists (N=347), other specialties (n=67) or general practitioner (n=38).

Mentions: Overall, 452 physicians (M=58.4%) participated in the initiative. Of those, 40.7% were aged 40–55 years, and 48.5% were over 55 years. Diabetologists and endocrinologists accounted for 76.8% of responders, GPs for 8.4%, whereas internists and other specialists for 14.8% (figure 1). The great majority of responders were from Italy (85.6%), but 75 participants were from other countries (mainly from Europe and from the USA, but also from Far and Middle East Asia, Africa, Oceania, and the Caribbean). Most of the responders worked at a hospital (79%), and 24.3% worked as private practitioners.


Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey.

Gallo M, Mannucci E, De Cosmo S, Gentile S, Candido R, De Micheli A, Di Benedetto A, Esposito K, Genovese S, Medea G, Ceriello A - BMJ Open Diabetes Res Care (2015)

Total respondents (N=452) divided according to specialty practice, that is, diabetologists/endocrinologists (N=347), other specialties (n=67) or general practitioner (n=38).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4537916&req=5

BMJDRC2015000109F1: Total respondents (N=452) divided according to specialty practice, that is, diabetologists/endocrinologists (N=347), other specialties (n=67) or general practitioner (n=38).
Mentions: Overall, 452 physicians (M=58.4%) participated in the initiative. Of those, 40.7% were aged 40–55 years, and 48.5% were over 55 years. Diabetologists and endocrinologists accounted for 76.8% of responders, GPs for 8.4%, whereas internists and other specialists for 14.8% (figure 1). The great majority of responders were from Italy (85.6%), but 75 participants were from other countries (mainly from Europe and from the USA, but also from Far and Middle East Asia, Africa, Oceania, and the Caribbean). Most of the responders worked at a hospital (79%), and 24.3% worked as private practitioners.

Bottom Line: The results of the survey show wide agreement (>90%) by participants on the utility of the algorithms proposed, even if they do not cover all possible needs of patients with T2DM for a personalized therapeutic approach.In the online survey period and in the months after its conclusion, a relevant and durable increase in the number of unique users who visited the websites was registered, compared to the period preceding the survey.Patients with T2DM are heterogeneous, and there is interest toward accessible and easy to use personalized therapeutic algorithms.

View Article: PubMed Central - PubMed

Affiliation: Department of Oncological Endocrinology , AOU Città della Salute e della Scienza-Molinette , Turin , Italy.

ABSTRACT

Objective: In recent years increasing interest in the issue of treatment personalization for type 2 diabetes (T2DM) has emerged. This international web-based survey aimed to evaluate opinions of physicians about tailored therapeutic algorithms developed by the Italian Association of Diabetologists (AMD) and available online, and to get suggestions for future developments. Another aim of this initiative was to assess whether the online advertising and the survey would have increased the global visibility of the AMD algorithms.

Research design and methods: The web-based survey, which comprised five questions, has been available from the homepage of the web-version of the journal Diabetes Care throughout the month of December 2013, and on the AMD website between December 2013 and September 2014. Participation was totally free and responders were anonymous.

Results: Overall, 452 physicians (M=58.4%) participated in the survey. Diabetologists accounted for 76.8% of responders. The results of the survey show wide agreement (>90%) by participants on the utility of the algorithms proposed, even if they do not cover all possible needs of patients with T2DM for a personalized therapeutic approach. In the online survey period and in the months after its conclusion, a relevant and durable increase in the number of unique users who visited the websites was registered, compared to the period preceding the survey.

Conclusions: Patients with T2DM are heterogeneous, and there is interest toward accessible and easy to use personalized therapeutic algorithms. Responders opinions probably reflect the peculiar organization of diabetes care in each country.

No MeSH data available.


Related in: MedlinePlus